BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10736631)

  • 1. Significance of genetic polymorphisms in cancer susceptibility.
    Hietanen E
    Adv Exp Med Biol; 1999; 472():241-51. PubMed ID: 10736631
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.
    Murata M; Watanabe M; Yamanaka M; Kubota Y; Ito H; Nagao M; Katoh T; Kamataki T; Kawamura J; Yatani R; Shiraishi T
    Cancer Lett; 2001 Apr; 165(2):171-7. PubMed ID: 11275366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of the human cytochrome P450 monooxygenase superfamily.
    Smith G; Stubbins MJ; Harries LW; Wolf CR
    Xenobiotica; 1998 Dec; 28(12):1129-65. PubMed ID: 9890157
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of CYP1A1, CYP2D6, GSTM1, and GSTT1 and susceptibility to acute lymphoblastic leukemia in Indian children.
    Aplenc R
    Pediatr Blood Cancer; 2004 Oct; 43(5):539-41. PubMed ID: 15382269
    [No Abstract]   [Full Text] [Related]  

  • 8. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
    Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
    Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
    Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
    Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individual susceptibility factors in the risk of lung cancer].
    Stücker I
    Ann Pathol; 1997; 17 Suppl 5():23-4. PubMed ID: 9453718
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytochromes P450 and cancer.
    Kaminsky LS; Spivack SD
    Mol Aspects Med; 1999; 20(1-2):70-84, 137. PubMed ID: 10575653
    [No Abstract]   [Full Text] [Related]  

  • 12. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among Lebanese.
    Darazy M; Balbaa M; Mugharbil A; Saeed H; Sidani H; Abdel-Razzak Z
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):423-9. PubMed ID: 21385088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glutathione-S-transferase (GSTM1, GSTP1, GSTT1) and cytochrome p450 (CYP1A1, CYP2D6) polymorphisms on numbers of basal cell carcinomas (BCCs) in families with the naevoid basal cell carcinoma syndrome.
    R Yang X; Pfeiffer RM; Goldstein AM
    J Med Genet; 2006 Apr; 43(4):e16. PubMed ID: 16582078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer.
    Lee HC; Yoon YB; Kim CY
    Korean J Intern Med; 1997 Jun; 12(2):128-36. PubMed ID: 9439147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
    Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
    Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biology of bronchial cancer. Molecular epidemiology].
    Urban T
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S13-4. PubMed ID: 10088222
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population.
    Saeed HM; Alanazi MS; Nounou HA; Salaby MA; Semlali A; Azzam N; Aljebreen A; Alharby O; Parine NR; Shaik J; Arafaha M
    Asian Pac J Cancer Prev; 2013; 14(6):3761-8. PubMed ID: 23886179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
    Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
    Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
    Muñoz S; Vollrath V; Vallejos MP; Miquel JF; Covarrubias C; Raddatz A; Chianale J
    Pharmacogenetics; 1998 Aug; 8(4):343-51. PubMed ID: 9731721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.